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Abstract
Epigenetic changes related to human disease cannot be fully addressed by studies of cells from cultures or from other
mammals. We isolated human fat cells from subcutaneous abdominal fat tissue of female subjects and extracted histones
from either purified nuclei or intact cells. Direct acid extraction of whole adipocytes was more efficient, yielding about
100 mg of protein with histone content of 60% –70% from 10 mL of fat cells. Differential proteolysis of the protein extracts
by trypsin or ArgC-protease followed by nanoLC/MS/MS with alternating CID/ETD peptide sequencing identified 19 histone
variants. Four variants were found at the protein level for the first time; particularly HIST2H4B was identified besides the only
H4 isoform earlier known to be expressed in humans. Three of the found H2A potentially organize small nucleosomes in
transcriptionally active chromatin, while two H2AFY variants inactivate X chromosome in female cells. HIST1H2BA and three
of the identified H1 variants had earlier been described only as oocyte or testis specific histones. H2AFX and H2AFY revealed
differential and variable N-terminal processing. Out of 78 histone modifications by acetylation/trimethylation, methylation,
dimethylation, phosphorylation and ubiquitination, identified from six subjects, 68 were found for the first time. Only 23 of
these modifications were detected in two or more subjects, while all the others were individual specific. The direct acid
extraction of adipocytes allows for personal epigenetic analyses of human fat tissue, for profiling of histone modifications
related to obesity, diabetes and metabolic syndrome, as well as for selection of individual medical treatments.
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Introduction
Adipose tissue has a central role in whole body energy
metabolism as a dynamic store of energy in the form of
triacylglycerols and as an endocrine organ that coordinates energy
stores with energy intake and utilization by other tissues. In type 2
diabetes this control is perturbed by an impaired response of the fat
cells to insulin [1,2]. This is a disease of environmental effects as it is
strongly linked to obesity and a sedentary lifestyle, but there is also a
well recognized genetic aspect. Around 30%–70% of the risk to get
type 2 diabetes has been attributed to the individual genetic
background and several recent genome-wide screens have identified
a number of genetic variations that carry an increased risk for the
disease [3]. The studies indicated that type 2 diabetes is a very
heterogeneous and polygenic disease with identified risk alleles of a
very low disease penetrance and high prevalence in the general
population [3]. On the other hand the intrauterine environments of
either rodents or humans appear to affect the probability of later
developing this disease [4–7] indicating the importance of
environmental influences and epigenetic factors independent of
the genetic predisposition. Epigenetic factors are recognized as
chromatin modifications at the level of DNA-methylation, histone
modifications and through RNA-interference.
Recent studies suggest that post-translational modifications
(PTMs) of histones may be related to insulin resistance [6,8–14].
Histones are part of a complex and dynamic gene expression
control via specific combinations of their modifications [15–18].
The most common PTMs of histones are acetylation, methylation
(mono-, di-, and tri-methylation), phosphorylation and ubiquitina-
tion, but also other modifications have been described, such as
sumoylation, ADP-ribosylation, citrullination, and biotinylation
[17,19,20]. However, epigenetic changes related to obesity and
diabetes cannot be reliably studied in cell cultures or in cells from
other animals. Primary human adipocytes contain a large droplet
of fat which occupies more than 95% of the cell volume. The high
oil content creates experimental problems to protein isolation from
primary human adipocytes. To enrich histones for proteomic
analysis one can take advantage of their basic properties and
solubility in acid. The most common approach is to extract basic
proteins from the nucleus, which means that nuclei first have to be
prepared from homogenized cells [21–26]. Extraction of histones
from whole insect cells [27] or mouse fibroblasts [28] has also been
used, as well as extractions of normal and cancer tissues using
HClO4 for isolation and characterization of the linker histone H1
variants [29,30].
In this work we isolated histones by acid extraction of isolated
nuclei and of whole primary human adipocytes. We found that a
substantially higher yield of histones of all subfamilies can be
achieved by direct acid extraction of the primary adipocytes, as
compared with extraction from isolated nuclei. The method is
suitable for direct mass spectrometric analyses of PTMs of
histones. Moreover, direct homogenization of cells in acid rapidly
terminates enzymatic reactions which otherwise can alter protein
modifications during the cell fractionation. At the subsequent step
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or Arg-C protease and analyzed peptides by LC/MS/MS with the
use of alternating CID and ETD fragmentation of peptide ions.
This study identified histone isoforms characteristic for primary
human adipocytes, revealed known and novel PTMs of these
proteins and provided the methodology for personal epigenetic
analyses and profiling of human fat tissues.
Materials and Methods
Isolation of human adipocytes
Samples of subcutaneous fat tissue were obtained during
ordinary elective abdominal surgery on female patients at the
University Hospital of Linko ¨ping. The study was approved by the
Regional Ethics Committee at Linko ¨ping University; all patients
obtained written information and gave their informed verbal
approval before the surgery, as approved by the ethics committee
considering that the procedure posed no discomfort or threat to
the health of the patients. Participating female subjects were 35–76
years old, with BMI ranging from 24.4 to 32.2 kg/m
2 and no one
of them was diagnosed with type 2 diabetes. The characteristics of
participating subjects are given in the Table S1. Adipocytes were
isolated from human tissue samples by collagenase (type 1,
Worthington, NJ, USA) digestion in Krebs-Ringer solution
essentially as described before [31]. At a final concentration of
about 25% cells were incubated in Krebs-Ringer solution and
Dulbecco’s Modified Eagle Medium (GIBCO), containing
200 nM adenosine, 25 mM HEPES, 100 u/mL penicillin and
100 mg/mL streptomycin, pH 7.4, at 37uC and 10% CO2 as
previously described [32]. Following the overnight incubation, the
cells were washed with Krebs-Ringer solution and incubated with
0.1 mM N6-phenylisopropyl adenosine and 2.5 mg/mL adenosine
deaminase for 10 min before further treatment.
Direct acid extraction of histones
Basic proteins from whole cells were extracted by acid. The cells
were homogenized in 0.33 M H2SO4 with five strokes in a
Dounce homogenizer, followed by 10 min centrifugation at 250 g,
and removal of floating oil. The pellet was resuspended in the
supernatant and incubated in a clean tube with slow rotation at
4uC for 2 h. Non-basic proteins were pelleted by centrifugation at
100 000 g for 60 min at 4uC and discarded. Trichloroacetic acid
was added to the supernatant up to 25% and the samples were
incubated on ice overnight. Proteins were pelleted by centrifuga-
tion at 100 000 g for 60 min at 4uC and washed 4 times with ice
cold acetone with centrifugations at 16 000 g for 12 min at 4uC.
Proteins were dissolved in 0.1 M HCl for protein determination by
Bradford reagent (BioRad, Richmond, CA) using a bovine serum
albumin standard curve. Finally the protein mixtures were dried,
dissolved in 50 mM NH4HCO3 and dried again, which was
repeated four times to remove residual acid.
Extraction of histones from nuclei
To isolate nuclei, the cells were washed and homogenized in
10 mM NaH2PO4, pH 7.4, 1 mM EDTA, 0.25 M sucrose,
25 mM NaF, 1 mM Na2-pyrophosphate, 0.5 mM EGTA,
4 mM iodoacetate, 2 mM Na3VO4,1 0 mM leupeptin, 1 mM
pepstatin, 1 mM aprotinin and 0.1 mM PMSF. Nuclei were
enriched and basic proteins extracted as previously described
[21,33]. Briefly the homogenized samples were layered on 0.8 M
sucrose in 0.5% NP-40, 10 mM NaCl, 10 mM KCl, 1.5 mM
MgCl2, 1 mM EDTA, 20 mM HEPES, pH 7.4 and centrifuged at
2 700 g for 15 min at 4uC. The pellet was washed with 0.25 M
sucrose in 10 mM NaCl, 10 mM KCl, 1.5 mM MgCl2,1m M
EDTA, 20 mM HEPES, pH 7.4 and then dissolved in 0.4 M
H2SO4. After incubation in the sulfuric acid with slow rotation at
4uC for 2 h, proteins were treated the same way as described for
whole cells above.
Analysis of histone recovery after direct acid extraction
To control the recovery of histones we used immunoblotting of
equal amounts of cell samples and of acid-extracted proteins, as
calculated from the volumes of the starting material and of the
final protein extract. The proteins were separated by SDS-PAGE
(14.5% acrylamide) and transferred to a polyvinylidene difluoride
blotting membrane (Immobilone-P, Millipore, MA, USA). The
membrane was mounted in a SNAP i.d. system (Millipore, MA,
USA), blocked with 0.5% BSA and then incubated with rabbit
polyclonal anti ‘‘Histone 3 C-terminal’’ or ‘‘Histone H2B’’
antibodies (Active Motif, Carlsbad, CA, USA). Bound antibodies
were detected by incubation with a secondary goat antibody
conjugated to horseradish peroxidase (Santa Cruz Biotechnical,
Santa Cruz, CA, USA) followed by ECL-plus (Amersham
Biosciences, Little Chalfont, Bucks, UK) and chemiluminescence
imaging (LAS 1000; Image Guage, Fuji, Tokyo, Japan) according
to the manufacturer’s instructions. The immunoblotting was
repeated three times for extracts from each analyzed subject
sample.
Analysis of proteins by in-gel digestion and MS/MS
Acid-extracted proteins from whole cells or nuclei were
separated on SDS-polyacrylamide gels (14% or 12% acrylamide)
and stained either with silver or with Coomassie Blue R-250
(BioRad, Richmond, CA, USA). Stained gels were scanned and
Photoshop Elements software (Adobe Systems, Mountain View,
CA) was used for intensity analysis. Protein bands were excised
from the gels, reduced with 10 mM DTT for 1 h at 56uC,
alkylated with 55 mM iodoacetamide for 1 h at room temperature
in darkness, and digested by trypsin for 4 h at 37uC essentially as
described [34]. The extracted peptide mixtures were desalted on
C18 reverse-phase ZipTips (Millipore) according to manufacturer’s
instructions. A 2 mL sample was loaded into a nanoelectrospray
capillary and analyzed using API Q-STAR Pulsar I mass
spectrometer (Applied Biosystems, Foster City, CA, USA). CID
of selected peptide ions was performed according to manufactur-
er’s settings with manual control of collision energy. All spectra
were analyzed manually as well as using MASCOT search engine
(http://www.matrixscience.com/) against the NCBInr database.
Analysis of all acid extracted proteins by microLC/MS/MS
The acid-extracted proteins were dissolved in 25 mM
NH4HCO3, pH 8.0, at a concentration of 1 mg/mL. For partial
digestion with trypsin, 2.5% sequence-grade modified trypsin from
Promega (Madison, WI, USA) was added and the mixture was
incubated for 4 h at 20uC. Digestion was terminated by addition
of 5% formic acid. To digest the proteins with ArgC-protease,
1.25% ArgC (sequencing grade endoproteinase ArgC from
Clostridium histolyticum, Roche) dissolved in 25 mM NH4HCO3
with 1 mM dithiothreitol was added and incubation was
performed for 1 h, 4 h or 20 h at 37uC. Digestions were
terminated by addition of 5% formic acid. The peptide mixtures
were dried and dissolved in 0.1% formic acid. The peptides were
analyzed by microLC/MS/MS using HCTultra PTM Discovery
System (Bruker Daltonics, Bremen, Germany). A 3060.32 mm
pre-column followed by a 15060.3 mm column, both reverse
phase C18 material with particle size 0.5 mm, were used for
separation of the peptides at a flow rate of 7 mL/min in a gradient
from 0.1% formic acid in water to 0.1% formic acid in 100%
Histones of Primary Human Fat Cells
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the first 19 min; 0%–5% B in 19–20 min; 5% B for 20–31 min;
5%–40% B in 31–110 min; 40%–90% B in 120–130 min. An
MS/MS method providing alternating CID and ETD fragmen-
tation of the multiply charged ions was used. Peak lists were
created from the raw data using Bruker Daltonics DataAnalysis
3.4 (Bruker Daltonics, Bremen, Germany). Resulting MGF files
were used for searches in NCBInr (20081116) on an in-house
Mascot server (version 2.2.06) (www.matrixscience.com). Search
parameters allowed data mass errors up to 0.7 Da for MS; for
MS/MS data 0.6 Da for CID ions and 1.3 Da for ETD ions were
used. The numbers of missed cleavages allowed were 3 and the
charge states were varied. Modifications allowed were N-terminal
acetylation (289.03 Da), acetylation of lysine (+42.01 Da),
monomethylation of lysine and arginine (+14.02 Da), dimethyla-
tion of lysine and arginine (+28.03 Da), ubiquitination of lysine
(+114.04 Da), oxidation of methionine (+15.99 Da) and phos-
phorylation of serine and threonine (+79.97 Da) in several
different combinations. Criteria for identification of a protein
were as follows: at least two peptides in the protein identified by
both CID and ETD or with a MASCOT score over 45, all spectra
also had to pass manual validation.
Histone analysis by nanoLC/MS/MS
For comparative analysis of histones from six different subjects
the acid-extracted proteins were dissolved in 25 mM NH4HCO3,
pH 8.0, at a concentration of 1 mg/mL and digested with trypsin
for 4 h at 20uC or with ArgC-protease for 1 h, 4 h or 20 h at
37uC, as described above. The digestions were terminated by
addition of 5% formic acid. The peptide mixtures were dried and
dissolved in 0.1% formic acid. The peptides were analyzed by
nanoLC/MS/MS using HCTultra PTM Discovery System
(Bruker Daltonics, Bremen, Germany). A 100 mm 62 cm pre-
column followed by a 3 mm; 75 mm610 cm column, both reverse
phase C18 material, were used for separation of the peptides at a
flow rate of 0.3 mL/min. The separation was performed in a
gradient from 0.1% formic acid in water (A) to 0.1% formic acid in
100% ACN (B) as follows: 5%–20% B in the first 120 min; 20%–
30% B in 120–150 min; 30%–100% B in 150–170 min; 100% B
for 170–180 min. Two automated MS/MS methods were used to
analyze each sample: one with alternating CID and ETD and the
second performing only ETD with exclusion of 1+ and 2+ ions.
The nanoLC/MS/MS analysis was implemented at least six times
for samples from each of all six subjects in the study.
Peak lists were created from the raw data using Bruker
Daltonics DataAnalysis 3.4 (Bruker Daltonics, Bremen, Germany)
and the resulting ETD.MGF files were used for searches in a small
human histone database containing all proteins (5170 entries)
found when searching the NCBI database for ‘‘Homo sapiens’’
[porgn:__txid9606] and H1, or H2A, or H2B, or H3 or H4 on an
in-house Mascot server (version 2.2.06) (www.matrixscience.com).
The peptide tolerance was set to 60.7 and the MS/MS tolerance
was 61.3. The number of missed cleavages allowed was 1 for
ArgC and 3 for trypsin and the charge states of the peptides were
varied between 2+,3 +,4 +,5 + and 6+. Allowed variable
modifications were: N-terminal acetylation (289.03 Da), acetyla-
tion of lysine (+42.01 Da), monomethylation of lysine and arginine
(+14.02 Da), dimethylation of lysine and arginine (+28.03 Da),
ubiquitination of lysine (+114.04 Da) and phosphorylation of
serine and threonine (+79.97 Da). To search all nine variable
modifications in our big data sets against a database like NCBI or
Swissprot an enormous data processing power is required. Thus,
to overcome this problem we created the small ‘‘human histone’’
database. Scaffold (version Scaffold_3.0.00, Proteome Software
Inc., Portland, OR) was used to validate the ETD based peptide
identifications. All MASCOT-search files for one subject were
loaded into scaffold and peptide identification criteria were as
follow: the peptide had to be found in at least two separate LC/
MS/MS experiments and pass a rigorous manual analysis
validation. If peptides matched more than one member of a
histone family the member with the highest coverage was
reported.
Results
Extraction of histones from isolated nuclei and from
whole cells
To analyze histones and their modifications in human
adipocytes we isolated adipocytes from abdominal subcutaneous
fat tissue of female subjects, obtained during elective surgery.
Extraction of proteins from primary human adipocytes is
challenging because of the limited amount of material and the
large droplet of fat that occupies most of the cell volume. Our first
approach was to isolate nuclei from adipocytes and then extract
basic proteins with acid, a protocol that has extensively been used
with other cell types [21–25] (outlined in Figure1A, left). SDS-
PAGE separation of the proteins extracted by acid from isolated
nuclei revealed a distinct protein pattern (Figure 1B, left lane), and
analysis of the major proteins by in-gel digestion and peptide
sequencing using ESI and Q-TOF analysis identified several
nuclear proteins, including histones H2A and H4. However, the
yield of these proteins was rather variable, depending on the
particular fat tissue sample. We therefore developed a technique
for histone extraction from whole cells (outlined in Figure 1A,
right; and B, right lane). We tried different concentrations of
sulfuric acid and found that 0.33 M H2SO4 was an optimal
concentration for extraction of the histones, which yielded 2–3
times as much protein as acid extraction from nuclei. This was due
to an increased yield of histones at the expense of non-histone
proteins (Figure 1B). From 9–10 mL of adipocytes we extracted
between 80 to 140 mg of protein. To characterize the extracted
proteins we separated them by SDS-PAGE, performed in-gel
digestion of 62 protein bands with trypsin and subsequent peptide
sequencing using a Q-TOF instrument. Among almost 20 proteins
identified by unambiguous sequencing of at least two peptides
(Figure 1C; Table 1) we found histones of all the subfamilies,
namely H1, H2A, H2B, H3 and H4. From the intensities of
Coomassie blue stained protein bands (Figure 1C) we estimated
that histones corresponded to 60%–70% of the total amount of
protein in the whole cell acid extract. Such a high yield of histone
proteins demonstrates a real advantage of the direct acid
extraction of the adipocytes.
We also analyzed the histone recovery after the direct acid
extraction of cells by SDS-PAGE and immmunoblotting using
antibodies against histones H3 and H2B. There were deviations
between different preparations, but in all of them we found
quantitative recovery of histone H3 and the recovery of H2B was
never less than 70% (Figure 1D). Further major advantages of this
technique are the elimination of time-consuming steps for isolation
of nuclei and the nearly instantaneous termination of all unwanted
enzymatic reactions at the time point when cells are homogenized
in the acid, which means that we preserve the natural PTMs of the
extracted basic proteins.
LC/MS/MS analysis of proteins extracted by acid from
whole cells
The procedure of protein in-gel digestion often causes the loss of
post-translationally modified peptides [35,36]. To make a
Histones of Primary Human Fat Cells
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also made digestions in solution, with either trypsin or ArgC-
protease, and analyzed the generated peptides by LC/MS/MS
using an ion trap performing alternating CID and ETD
fragmentations of peptide ions. For identification of proteins we
used MASCOT database search with the following criteria:
Figure 1. Comparison of histone preparations from nuclei and from whole cells. (A) A scheme for histone preparations from nuclei (left)
and via whole cell extraction (right). (B) Silver stained SDS-PAGE gels with proteins extracted from nuclei and separated on a 14% acrylamide gel (left),
and proteins extracted from whole cells and separated on a 12% acrylamide gel (right). Protein bands were cut out and in-gel digested with trypsin,
the peptides were analyzed using ESI-MS/MS. Identified histones are indicated to the right. (C) Coomassie stained SDS-PAGE gel with proteins
extracted from whole cells showing protein bands identified by MS/MS after in-gel digestion with trypsin. The numbers to the right indicate positions
of the bands and histones as it specified in the Table 1. Molecular masses of reference proteins are indicated to the left of the gels in B and C.
(D) Western blots showing efficiency of the direct acid extraction of histones from the cells by comparing immunoresponse of the samples
corresponding to the equal amounts of total cell (TC) and acid extract (AE) from two different subjects. The antibodies against H3 and H2B were used,
as indicated.
doi:10.1371/journal.pone.0015960.g001
Table 1. Proteins from acid extracted whole cells identified by MS/MS after in-gel digestion.
Protein NCBI acc. number Band
1 MW (kDa) pI
Cellular
location
2
Number of
peptides
Annexin A1 GI:4502101 26 38.7 6.6 Cyt, Nuc 2
Alpha 2 globin GI:4504345 56, 57 15.3 8.7 Rbc 3
Beta globin GI:71727161 56 16.0 7.8 Rbc 7
Chaperonin 10 GI:4008131 59 10.6 9.4 Mt 2
Crystallin, alpha B GI:4503057 38, 39 20.0 6.8 3
Fatty Acid Binding Protein 4 GI:4557579 56 15.0 6.6 Nuc, Cyt 3
Gamma synuclein GI:3347842 51 13.3 5.0 Cyt 2
Histone H1 GI:4885375 26, 28, 29 22.0 11.0 Nuc 6
Histone H2A GI:28195394 52, 53, 54 14.0 10.9 Nuc 4
Histone H2B GI:1568557 51, 52 14.0 10.3 Nuc 7
Histone H3 GI:1568559 50, 51 15.0 11.3 Nuc 3
Histone H4 GI:51315727 52,54,56,57,59 11.0 11.0 Nuc 7
PTRF GI:42734430 54 43.5 5.5 Nuc, Mem 2
Ribosomal protein S18 GI:119624103 48 16.3 9.7 Rb 3
Ribosomal protein S19 GI:4506695 52 16.1 10.3 Rb 2
S100 Calcium binding protein A6 GI:7657532 62 10.2 5.3 Cyt, NucE 2
S100 Calcium binding protein A10 GI:4506761 58, 60, 61 11.2 6.8 Mt 6
S100 calcium binding protein A11 GI:5032057 58, 59 11.7 6.6 Cyt, Nuc 3
Vimentin GI:62414289 13 53.7 5.1 Cyt 4
1: bands are marked in Figure 1C.
2: Mt = mitochondrion, Nuc = nucleus, Rb = ribosome, NucE = nuclear envelope, Rbc = red blood cells, Mem = membrane, Cyt = cytoplasm.
doi:10.1371/journal.pone.0015960.t001
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tion or have a MASCOT score above 45, as well as be confirmed
by manual validation of the fragmentation spectra. We identified
31 proteins with vimentin, plasma membrane protein S3-12,
which is a lipid droplet associated protein, and histones as the best
hits (Table S2). Vimentin and plasma membrane protein S3-12
have much higher molecular masses compared with histones; they
thus produced a high number of peptides resulting in a high score.
However, as shown by analyses of protein band intensities in
Coomassie blue-stained gels (Figure 1C), the histone bands
represented the major protein content in the whole cell acid
extract. There was a significant difference between in-gel digestion
followed by Q-TOF MS/MS compared to LC/MS/MS.
Vimentin was for example identified by 4 peptides using in-gel
digestion followed by Q-TOF MS/MS and by 27 peptides using
LC/MS/MS; and plasma membrane protein S3-12, which was
identified by 30 peptides with LC/MS/MS, was not found using
in-gel digestion and Q-TOF MS/MS of the same sample.
Optimization of histone analyses
Histones contain many lysines and arginines, especially in their
flexible termini, which also are the most interesting parts of these
proteins concerning PTMs. The frequently occurring lysines and
arginines produce very small peptides when the histones are
digested with trypsin. We therefore limited the digestion with
trypsin to only 4 h at room temperature to create an incomplete
digestion and thus formation of longer peptides, which are more
suitable for characterization of modified amino acids. Moreover,
we also used ArgC-protease for 1 h, 4 h or 20 h to have both
complete and incomplete digestion of the proteins with this
protease. Controlled proteolysis by trypsin or ArgC-protease
combined with LC/MS/MS using CID and ETD fragmentation
allowed us to gather sequence information from complementary
peptides that differed in length and ionization states. Modifications
by acetylation and trimethylation cannot be distinguished under
the conditions of the study, thus we annotate all +42 Da
modifications except for N-terminal acetylations in this work as
acetylation/trimethylation (ac/me3).
During optimization of the peptide analyses we first used
protein digests from five subjects and found that the main
challenge of the study was in the extremely high variability of the
peptide patterns between the subjects. This variability originated
from different histone variants as well as from diverse and multiple
peptide modifications. For instance, the H2AFZ variant, which is
known to substitute for the canonical H2A histones and change
the chromatin structure to affect the promoter regions of specific
genes [37,38], was found in two out of five subjects by sequencing
of five differentially processed peptides corresponding to the N-
terminus of this histone (Figure 2). Only one of the peptides
contained the N-terminal methionine (Figure 2A), while in the
other four this residue had been removed (Figure 2B–E). Besides
the alternative removal of the methionine, the N-terminal peptides
of H2AFZ were differentially modified and contained between
three to five different modifications by methylation, acetylation/
trimethylation, phosphorylation and ubiquitination (Figure 2). To
increase the reliability of peptide identification we substituted
microLC/MS/MS by nanoLC/MS/MS and made six LC/MS/
MS analyses for each acid extracted sample from six additional
subjects. All identified peptide variants, modified as well as non-
modified, were sequenced in at least two separate LC/MS/MS
runs of histones extracted from the same person and all spectra
were manually verified. These LC/MS/MS runs corresponded to
samples digested by the ArgC-protease for 1 h, 4 h or 20 h, each
with a technical replicate. They resulted in the identification of 18
histone isoforms carrying 78 different modifications (Tables 2, 3, 4,
5, 6). Notably, in one of the six additional subjects we found yet
another N-terminal peptide variant from H2AFZ which contained
the initial methionine and four other residues modified by
ubiquitination and dimethylation (Figure 2F).
Advantage of peptide fragmentation by ETD
General proteomic studies have not found ETD preference over
CID peptide ion analysis [39], while the combined use of ETD
and CID MS/MS have been shown to increase the total number
of identified modified peptides [40,41]. We found that using ETD
was absolutely critical for the identification of heavily modified
human histone variants. At the initial stage of the study when we
analyzed protein digests from five subjects by microLC/MS/MS
we found 64 histone peptides: 35 were detected with both CID
and ETD fragmentation, 2 only with CID and 27 only with ETD.
The peptides sequenced exclusively by ETD contained the vast
majority out of 78 identified PTMs. Thus, for detection of the
modified peptides at the following stage we focused on the
MASCOT database searches using ETD data sets obtained using
nanoLC/MS/MS.
Figure 3 presents the ETD fragmentation spectrum of the 28
amino acid long, modified C-terminal peptide of HIST1H2BN, a
histone variant not characterized at the protein level before our
study but only known from the human genome sequence [42].
This spectrum with the MASCOT ions score 77 and the expect
value of 1.7e-05 identifies an earlier unknown cluster of modified
sites with Ser-125 phosphorylation, Lys-126 acetylation/trimethy-
lation, Lys-127 ubiquitination and Arg-128 dimethylation. The
ubiquitination of Lys-127 is of special interest because the C-
terminal H2B ubiquitination is an evolutionarily conserved histone
crosstalk mechanism regulating chromatin dynamics and the
trans-histone H3 methylation [43]. Ubiquitination of Lys-123 in
yeast histone H2B enhances nucleosome stability [44] and,
notably, the residues Arg-119 and Thr-122 in the H2B C-terminal
helix play a direct role in controlling this ubiquitination, as well as
methylation of the Lys-4 in histone H3 [45]. Thus, the cluster of
modifications around ubiquitinated Lys-127 in HIST1H2BN
(Figure 3), found only due to the application of ETD, may have
similar regulatory functions.
Variants for the first time found at the protein level
We sequenced peptides from four human histone variants,
namely HIST1H2BN, H2A (fragment), the protein ‘‘similar to
H2AFY2’’ and HIST2H4B, which have previously only been
found at cDNA or gene levels [42,46,47]. The unique quadruply
modified peptide from HIST1H2BN (Figure 3) was found in cells
from three persons, while the same peptide was identified from one
more person with alternative modifications: Ser-124 and Ser-125
phosphorylations and Lys-126 and Lys-127 acetylations/trimethy-
lations (Table 4, Figure S2B). The peptides from the H2A
(fragment) and the protein ‘‘similar to H2AFY2’’ (Table 3, Figure
S2A) were sequenced from the acid protein extracts obtained from
the fat tissue of two and three different subjects, respectively. The
isoform of histone H4, HIST2H4B, was identified from three
persons with the specific N-terminal peptide differently modified
either by Lys-8 and Lys-16 ubiquitination or by Lys-8 mono-
methylation and Lys-16 dimethylation (Table 6, Figure S4). These
four histone variants found at the protein level for the first time
contained 13 previously unknown PTMs (Tables 3, 4 and 6).
Histone H1 analysis
We identified five histone H1 variants: HIST1H1E,
HIST1H1T, H1F0, H1FOO and H1FNT (Table 2). H1F0 was
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PLoS ONE | www.plosone.org 5 January 2011 | Volume 6 | Issue 1 | e15960Figure 2. Differentially processed and modified N-termini of histone H2AFZ. ETD fragmentation spectra corresponding to six differentially
processed N-terminal peptides of the variant H2AFZ (GI: 4504255). A–E show peptides identified in the histone analysis optimization process, while F
presents the spectrum of the peptide identified during the following nanoLC/MS/MS analysis of six different subjects. The positions of z,y (C-terminal)
and c (N-terminal) fragment ions are indicated in the spectra and in the presented peptide sequences with the lower case (ac/me3) (me1), (me2), (ph)
and (ub) corresponding to modifications of the amino acids by acetylation/trimethylation, monomethylation, dimethylation, phosphorylation and
ubiquitination, respectively. (A) ETD spectrum of the ion (M+3H)
3+ at m/z 845.5 corresponding to the peptide with the amino acid positions 1–23 in
H2AFZ. The peptide is modified by methylation, acetylation/trimethylation, and two phosphorylations. The mass difference of 167 between the
fragment ions z13 and z14 corresponds to the phosphorylated serine at the position 10. (B) ETD spectrum of the peptide corresponding to the amino
acid positions 2–20; the ion (M+3H)
3+ at m/z 670.4. The peptide is modified by two monomethylations, two acetylations/trimethylations and a
phosphorylation. The mass difference of 170 between the fragment ions z6 and z7 corresponds to the acetylated/trimethylated lysine at the position
13. (C) ETD spectrum of the peptide corresponding to the amino acid positions 2–20; the ion (M+3H)
3+ at m/z 651.8. The peptide is modified by
monomethylation, acetylation/trimethylation and phosphorylation. The mass difference of 170 between the fragment ions c14 and c15 corresponds
to the acetylated/trimethylated lysine at the position 15. (D) ETD spectrum of the peptide corresponding to the amino acid positions 2–20; the ion
(M+3H)
3+ at m/z 701.1. The peptide is modified by two ubiquitinations, monomethylation and acetylation/trimethylation. The mass difference of 242
between the fragment ions z12 and z13 corresponds to the ubiquitinated lysine at the position 7. (E) ETD spectrum of the peptide corresponding to
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abundant histone protein H1.4, was found in all studied subjects.
HIST1H1T, H1FOO and H1FNT were, however, found in
adipocytes of one person each, probably indicating the low
abundance of these histone variants, which have been considered
to be oocyte and testis specific [48–50]. The initial methionine of
HISTH1E was found to be removed and the following N-terminal
serine was acetylated. N-terminal processing and acetylation of
H1F0 was found as well (Table 2). H1FOO was modified by Lys-
199 monomethylation and Arg-215 dimethylation, while
HIST1H1T was modified by Thr-159 phosphorylation which
has been mapped before [51] (Table 2, Figure S1). H1FNT was
found dimethylated at the Lys-184 (Table 2, Figure S1).
Histone H2A analysis
We identified six different variants of the histone H2A subfamily
in the human adipocytes: H2AFZ, H2AFX, H2AFY,
HIST1H2AC, a protein variant called histone H2A (fragment),
the amino acid positions 2–16; the ion (M+3H)
3+ at m/z 547.4. The peptide is modified bythreemonomethylations,phosphorylationandubiquitination.
Themass differenceof242betweenthefragment ionsz2 andz3 correspondstothe ubiquitinatedlysineandthemass differenceof142betweenfragment
ions z4 andz5 corresponds tothemonomethylatedlysine. (F)ETD spectrum ofthe ion (M+4H)
4+ at m/z 630.5 corresponding to the peptide with the amino
acid positions 1–23 in H2AFZ. The peptide is modified by ubiquitination and three dimethylations. The mass difference of 242 between the fragment ions
c11 and c12 and the difference of 141 between the doubly charged fragment ions z11
2+ and z12
2+ correspond to the ubiquitinated lysine.
doi:10.1371/journal.pone.0015960.g002
Table 2. Histone H1 peptides identified using LC/MS/MS of the acid extracted proteins digested by either trypsin or ArgC.
Protein Peptide sequence AA M/Z Z Score/E-value
HIST1H1E, protein name: H1.4, GI:4885379, Acc: NP_005312, Coverage: 36%
(ac)-SETAPAAPAAPAPAEKTPVKKKAR 2–25 810.9 3+ 61/0.00057
608.5 4+ 40/0.074
KASGPPVSELITK 34–46 664.0 2+ 65/0.0067
443.0 3+ 60/0.018
ASGPPVSELITK 35–46 599.9 2+ 67/0.0041
KASGPPVSELITKAVAASKER 34–54 714.3 3+ 100/5.8e-08
536.1 4+ 74/2.6e-05
429.3 5+ 90/5.5e-07
SGVSLAALK 55–63 423.3 2+ 71/0.0011
SGVSLAALKKALAAAGYDVEKNNSR 55–79 1268.1 2+ 80/7.3e-06
845.8 3+ 87/1.6e-06
634.7 4+ 90/9.2e-07
507.7 5+ 96/1.7e-07
ALAAAGYDVEK 65–75 554.3 2+ 80/0.00015
GTGASGSFK 95–106 406.2 2+ 35/0.52
HIST1H1T, protein name: histone H1t, GI:20544168, GI:184084, Acc: NP_005314, Acc: AAA19936, Coverage: 16%
ALAAAGYDVEK 69–79 554.3 2+ 80/0.00015
GTGASGSFK 102–110 406.2 2+ 35/0.52
AKKPRAT(ph)TPKTVR 153–165 512.6 3+ 41/0.017
H1F0, protein name: H1.0, GI:4885371, Acc: NP_005309, Coverage: 18%
(ac)-TENSTSAPAAKPKR 2–15 500.0 3+ 47/0.0065
LVTTGVLKQTKGVGASGSFR 75–94 669.9 3+ 70/5.1e-05
502.4 4+ 75/2e-05
H1FOO, protein name: histone H1oo, GI:28839618, Acc: AAH47943, Coverage: 8%
K(me1)QGGAAKDTRAQSGEAR(me2) 199–215 887.8 2+ 34/0.15
592.2 3+ 46/0.012
H1FNT, protein name: testis-specific H1, GI:44953495, Acc: AAS49492, Coverage: 6%
AK(me2)EEAGATAADEGR 183–196 468.6 3+ 29/0.17
AA - amino acids of the peptide numbered in the sequence of corresponding protein; M/Z - mass over charge ratio; Z – ion charge.
ac - acetylation, me1 - monomethylation, me2 - dimethylation, ph – phosphorylation.
doi:10.1371/journal.pone.0015960.t002
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the variants was found in adipocytes of all six participating
persons. Histone H2A (fragment) and the protein ‘‘similar to
H2AFY2’’ have previously only been found at cDNA or gene
levels [42,46,47]. The peptides from the H2A variants were
sequenced with different PTMs (Table 3, Figure S2A). Only one of
these modifications was known from previous studies of a human
myeloid leukemia cell line: acetylation of the Lys-6 in H2AFX
[52]. The following 32 modifications we found for the first time: in
H2AFZ Lys-12 ubiquitination and dimethylations of Lys-16, Arg-
20 and Arg-23; in H2AFX Lys-6 ubiquitination or monomethyla-
tion, Thr-7 and Ser-17 phosphorylations, Lys-10, Lys-16 ubiqui-
tination, Arg-12 and Lys-14 monomethylations, and dimethyla-
tions of the Arg-12 and Lys-14, Lys-16; in H2AFY Ser-3 and Thr-
10 phosphorylation, Lys-7, and Lys-12 acetylations/trimethyla-
tions, Lys 7, -8, -9, -12, and Arg-15 monomethylations, Lys-8, and
Arg-15 dimethylations and Lys-7, -8 and -9 ubiquitinations; in
H2A (fragment) Lys-6 acetylation/trimethylation; and in the
protein similar to H2AFY2 Arg-4 monomethylation and Ser-11
phosphorylation (Table 3, Figure S2A).
In addition to identification of the novel PTMs described above,
we revealed a differential N-terminal processing and modification
pattern for the H2AFX variant. H2AFX, also known as the
histone H2A.x protein, is the abundant histone variant involved in
the repair of double stranded DNA breaks [53,54]. Removal of the
initial methionine in H2AFX with the following acetylation of the
N-terminal serine is expected by similarity according to uniprot
(http://www.uniprot.org/uniprot/P16104). We experimentally
demonstrated it here for the first time (Table 3, Figure 4A).
Moreover, we also found the alternative N-terminal processing of
H2AFX by removal of the first four amino acids and acetylation of
Gly-5 (Table 3, Figure 4C,D). On top of this alternative N-
terminal processing, each of the four sequenced peptides contained
from one to four additional modifications by differential
ubiquitination, monomethylation, phosphorylation, and dimethy-
lation (Table 3, Figure 4).
Table 3. Histone H2A peptides identified using LC/MS/MS of the acid extracted proteins digested by either trypsin or ArgC.
Protein Peptide sequence AA M/Z Z Score/E-value
H2AFZ, protein name: histone H2A.Z, GI:4504255, Acc: NP_002097, Coverage: 31%
MAGGKAGKDSGK(ub)AKTK(me2)AVS-
R(me2)SQR(me2)
1–23 630.4 4+ 29/0.97
AGLQFPVGR 24–32 473.3 2+ 59/0.00025
HLQLAIR 86–92 426.0 2+ 34/0.041
H2AFX, protein name: H2A.x, GI:4504253, Acc: NP_002096, Coverage: 36%
(ac)-SGRGKTGGKAR(me1) 2–12 377.6 3+ 37/0.046
GK(ac/me3)T(ph)GGK(ub)AR(me2)AKA-
K(me2)SR
5–18 570.1 3+ 41/0.044
(ac)-GK(ub)TGGKARAK(me1)AK(ub)SR 5–18 567.6 3+ 37/0.053
(ac)-GK(me1)TGGKARAK(me2)AKS(ph)R 5–18 527.6 3+ 20/2
AGLQFPVGR 24–32 473.2 2+ 59/0.00025
HLQLAIR 83–89 426.0 2+ 34/0.041
VTIAQGGVLPNIQAVLLPK 101–119 966.1 2+ 89/2.4e-005
H2AFY, protein name: core histone macro H2A.1, GI:15426458, Acc: AAH13331, Coverage: 4%
MSSRGGK(ac/me3)K(me2)KSTKTSR 1–15 571.0 3+ 28/0.63
SS(ph)RGGKK(me1)K(me1)STKTSR(me2) 2–15 549.3 3+ 41/0.023
SS(ph)RGGKKK(me1)STK(me1)TSR(me2) 2–15 549.4 3+ 49/0.0044
SS(ph)RGGK(me1)KKSTK(me1)TSR(me2) 2–15 549.2 3+ 31/0.24
GK(ub)K(ub)K(ub)ST(ph)K(ac/me3)TSR(me1) 6–15 533.7 3+ 32/0.14
‘‘similar to H2AFY2’’, unnamed protein product, GI:10433885, Acc: BAB14049, Coverage: 5%
SGR(me1)SGKKKMS(ph)NLSR 2–15 544.5 3+ 53/0.001
HIST1H2AC, protein name: H2A type 1-B/E, GI:24496274, Acc: AAN59965, Coverage: 29%
HLQLAIRNDEELNKLLGR 83–100 712.3 3+ 21/7.6
534.7 4+ 40/0.069
HLQLAIR 83–89 426.0 2+ 34/0.041
VTIAQGGVLPNIQAVLLPK 101–119 966.1 2+ 89/2.4e-005
644.5 3+ 65/0.008
histone H2A (fragment), GI:2118981, Acc: I79341, Coverage: 47%,
GK(ac/me3)QGGKAKSRSSR 5–17 463.7 3+ 27/0.38
AGLQFPVGR 24–32 473.3 2+ 59/0.00025
AA - amino acids of the peptide numbered in the sequence of corresponding protein; M/Z - mass over charge ratio; Z – ion charge.
ac - acetylation, ac/me3 - acetylation/trimethylation, me1 - monomethylation, me2 - dimethylation, ph - phosphorylation, ub – ubiquitination.
doi:10.1371/journal.pone.0015960.t003
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Protein Peptide sequence AA M/Z Z Score/E-value
HIST1H2BM, protein name: Histone H2B type 1-M, GI:45767717, Acc: AAH67487, Coverage: 94%
PEPVK(ac/me3)S(ph)APVPK(me1)K(me1)GSK-
K(me2)AINKAQKKDK(ub)K(ub)RK(me1)R
2–31 642.3 6+ 44/0.096
QVHPDTGISSK 48–58 584.7 2+ 58/0.011
AMGIMNSFVNDIFER 59–73 872.5 2+ 109/4e-007
582.2 3+ 68/0.0059
IAGEASR 74–80 352.2 2+ 52/0.037
LAHYNK 81–86 373.2 2+ 31/10
STITSREIQTAVR 88–100 732.0 2+ 77/4.4e-06
488.2 3+ 69/4.7e-05
EIQTAVR 94–100 409.0 2+ 51/0.0026
LLLPGELAKHAVSEGTKAVTKYTSSK 101–126 911.0 3+ 49/0.014
683.5 4+ 33/0.57
546.9 5+ 104/2.6e-08
456.2 6+ 125/2.6e-10
LLLPGELAKHAVSEGTKAVTK(ac/me3)YTS-SK(ac/
me3)CASR(me2)
101–130 543.9 6+ 37/0.2
HIST1H2BA, protein name: H2ba, GI:4254257, Acc: AAH66240, Coverage: 50%
QVHPDTGISSK 49–59 584.7 2+ 58/0.011
IASEAPR(me2)LAHYS(ph)K(ac/me3)R(me1) 75–88 588.8 3+ 38/0.12
442.1 4+ 37/0.12
STISSR(me1)EIQTAVR 89–101 488.4 3+ 47/0.0064
EIQTAVR 95–101 409.0 2+ 51/0.0026
LLLPGELAKHAVSEGTKAVTKYTSSK 102–127 911.0 3+ 49/0.014
683.5 4+ 33/0.57
546.9 5+ 104/2.6e-08
456.2 6+ 125/2.6e-10
HIST1H2BN, protein name: H2bn, GI: 119623520, Acc: EAX03115, Coverage: 48%
QVHPDTGISSK 49–59 584.7 2+ 58/0.011
AMGIMNSFVNDIFER 60–74 872.5 2+ 109/4e-007
582.2 3+ 68/0.0059
IAGEASR 75–81 352.2 2+ 52/0.037
LAHYNK 82–87 373.2 2+ 31/10
STITSREIQTAVR 88–100 732.0 2+ 77/4.4e-06
488.2 3+ 69/4.7e-05
EIQTAVR 94–100 409.0 2+ 51/0.0026
LLLPGELAKHAVSEGTKAVTKYTSSK 101–126 911.0 3+ 49/0.014
683.5 4+ 33/0.57
546.9 5+ 104/2.6e-08
456.2 6+ 125/2.6e-10
LLLPGELAKHAVSEGTKAVTKYTSS(ph)-
K(ac/me3)K(ub)R(me2)
101–128 547.1 6+ 77/1.7e-05
LLLPGELAKHAVSEGTKAVTKYTS(ph)-
S(ph)K(ac/me3)K(ac/me3)R
101–128 543.8 6+ 40/0.09
HIST1H2BJ, protein name: H2B type 1-J, GI:20336754, Acc: NP_066402, Coverage: 38%
QVHPDTGISSK 48–58 584.7 2+ 58/0.011
AMGIMNSFVNDIFER 59–73 872.5 2+ 109/4e-007
582.2 3+ 68/0.0059
IAGEASR 74–80 352.2 2+ 52/0.037
LAHYNK 81–86 373.2 2+ 31/10
STITSREIQTAVR 88–100 732.0 2+ 77/4.4e-06
488.2 3+ 69/4.7e-05
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In the human adipocytes we identified four different variants of
histone H2B: HIST1H2BM, HIST1H2BA, HIST1H2BN and
HIST1H2BJ (Table 4). The variant HIST1H2BN, not found at
the protein level before this study, was identified by sequencing of
two differentially modified C-terminal peptides from four subjects,
as described above. These peptides contained seven novel
modifications by phosphorylation, acetylation, ubiquitination and
dimethylation (Table 4, Figure 3, Figure S2B). The 30 amino acids
long N-terminal peptide from HIST1H2BM was sequenced using
ETD, which revealed eight modifications by Lys-6 acetylation/
trimethylation, Ser-7 phosphorylation, Lys-12, Lys-13 and Lys-30
monomethylations, Lys-17 dimethylation and Lys-27 and Lys-28
ubiquitinations (Table 4, Figure S2B). Out of these modifications,
only the acetylation of the Lys-6 has previously been described in
human myeloid leukemia and airway epithelial cell lines [52,55].
We also sequenced the C-terminal peptide from HIST1H2BM,
which was modified by Lys-121 and Lys-126 acetylations/
trimethylations and Arg-130 dimethylation, none of which have
been published before. HIST1H2BM was sequenced with a
coverage of 94% (Table 4, Figure S2B), the highest of all histones
found in the study. The other variant HIST1H2BA was sequenced
with a coverage of 50% (Table 4). This variant has earlier been
described as a testis/sperm-specific replacement histone H2B with
unknown biological function [56]. We identified two modified
peptides from HIST1H2BA: one carrying Arg-81 dimethylation,
Ser-86 phosphorylation, Lys-87 acetylation/trimethylation and
Arg-88 monomethylation, and the other peptide monomethylated
at Lys-94 (Table 4, Figure S2B). Both peptides were found in cell
extracts from two different persons and none of the found
modifications was previously known. Most of the unmodified H2B
peptides were found in the adipocytes from all six studied subjects.
Histone H3 analysis
We identified the isoforms HIST1H3I and H3F3A/H3F3B
from the histone H3 subfamily. A peptide sequenced with Lys-24
acetylation/trimethylation was found in both isoforms, but the one
carrying Lys-28 and Lys-37 dimethylations was specific for
H3F3A/H3F3B, also known as the histone variant H3.3
(Table 5, Figure S3). This peptide was found in adipocytes from
two of the studied subjects and so was the unmodified peptide
specific for HIST1H3I. The histone H3 family is so far the most
studied and all three modifications that we sequenced were
previously known [57]. Notably, the N-terminal peptides from
both H3 variants that we sequenced with high confidence started
from the amino acid residue 19 of their translation products
Protein Peptide sequence AA M/Z Z Score/E-value
EIQTAVR 94–100 409.0 2+ 51/0.0026
LLLPGELAKHAVSEGTKAVTKYTSAK 101–126 679.3 4+ 50/0.0083
543.9 5+ 78/1.4e-05
AA - amino acids of the peptide numbered in the sequence of corresponding protein; M/Z - mass over charge ratio; Z – ion charge.
ac - acetylation, ac/me3 - acetylation/trimethylation, me1 - monomethylation, me2 - dimethylation, ph - phosphorylation, ub – ubiquitination.
doi:10.1371/journal.pone.0015960.t004
Table 4. Cont.
Table 5. Histone H3 peptides identified using LC/MS/MS of the acid extracted proteins digested by either trypsin or ArgC.
Protein Peptide sequence AA M/Z Z Score/E-value
H3F3A/H3F3B, protein name: H3.3, GI:4504279, Acc: NP_002098, Coverage: 45%
KQLATK(ac/me3)AAR 19–27 515.2 2+ 41/0.012
K(me2)SAPSTGGVK(me2)KPHR 28–41 503.5 3+ 60/0.00031
YRPGTVALREIR 42–53 477.6 3+ 44/00.1
LVREIAQDFKTDLR 71–84 569.3 3+ 60/0.00079
EIAQDFKTDLR 74–84 668.5 2+ 34/0.084
466.0 3+ 44/0.0083
VTIMPKDIQLAR 118–129 463.0 3+ 35/0.084
HIST1H3I, protein name: histone cluster 1, H3.i, GI:45219796, Acc: AAH66884, Coverage: 35%
KQLATK(ac/me3)AAR 19–27 515.2 2+ 41/0.012
YRPGTVALREIR 42–53 477.6 3+ 44/00.1
LVREIAQDFKTDLR 71–84 569.3 3+ 60/0.00079
EIAQDFKTDLR 74–84 668.5 2+ 34/0.084
466.0 3+ 44/0.0083
VTIMLKDIQLAR 118–129 701.5 2+ 43/0.014
468.0 3+ 54/0.00096
AA - amino acids of the peptide numbered in the sequence of corresponding protein; M/Z - mass over charge ratio; Z – ion charge.
ac/me3 - acetylation/trimethylation, me2 – dimethylation.
doi:10.1371/journal.pone.0015960.t005
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of histone H3 were also detected but intensity of their signals was
always very low, which resulted in fragmentation spectra and
sequencing quality that did not pass the identification criteria of
this work. Figure S5 demonstrates an example of not accepted
identification for the N-terminal peptide, the amino acids 3–18 of
the histone H3, with six modified residues detected in the
MASCOT search. The ion fragmentation spectrum had a low
MASCOT score, a high E-value and was not considered as
peptide identification, although it was found in several LC/MS/
MS runs from the same subject. We suggest that the diversity of
the H3 N-terminal modifications in the primary adipocytes results
in numerous heterogeneous N-terminal peptide products, which
decreases the probability of obtaining a high quality MS/MS
fragmentation for each of them.
Histone H4 analysis
Histone H4 is considered to be expressed in humans as only one
protein [58]. The N-terminal peptide of this protein, originating
from the genes HIST1H4A-L/HIST2H4A-B/HIST4H4, was found
to be modified by previously known [59] dimethylation of Lys-21,
and Lys-9 acetylation (Table 6). We also observed an earlier
Table 6. Histone H4 peptides identified using LC/MS/MS of the acid extracted proteins digested by either trypsin or ArgC.
Protein Peptide sequence AA M/Z Z Score/E-value
HIST2H4B, GI:124504316, Acc: AAI28106, Coverage: 85%
VWRGKGGK(ub)GLGKGGAK(ub)R 1–17 647.8 3+ 45/0.016
VWRGKGGK(me1)GLGKGGAK(me2)R 1–17 585.6 3+ 53/0.001
GK(me2)GGK(ac/me3)GLGKGGAK(ub)R 4–17 486.0 3+ 31/0.23
GK(ub)GGKGLGK(me1)GGAK(ub)R(me2) 4–17 514.6 3+ 44/0.016
K(me2)VLRDDIQGITKPAIR 20–35 617.9 3+ 75/2.1e-05
463.8 4+ 81/4.3e-06
K(me2)VLRDNIQGITKPAIR 20–35 618.0 3+ 54/0.0028
DDIQGITKPAIR 24–35 664.2 2+ 30/0.26
443.1 3+ 64/8.6e-05
DNIQGITKPAIR 24–35 663.9 2+ 59/0.00017
443.0 3+ 68/5.3e-05
ISGLIYEETR 46–55 591.4 2+ 88/2.2e-07
GVLKVFLENVIR 56–67 694.4 2+ 57/0.00055
463.3 3+ 53/0.0014
VFLENVIR 60–67 495.5 2+ 53/0.0012
DAVTYTEHAK 68–77 567.8 2+ 49/0.21
KTVTAMDVVYALKR 79–92 532.8 3+ 80/2.6e-06
TVTAMDVVYALK 80–90 655.9 2+ 65/0.0052
HIST1H4A-L/HIST2H4A-B/HIST4H4, GI: 4504301, Acc: NP_003529, Coverage: 74%
GK(me2)GGK(ac/me3)GLGKGGAK(ub)R 5–18 486.0 3+ 31/0.23
GK(ub)GGKGLGK(me1)GGAK(ub)R(me2) 5–18 514.6 3+ 44/0.016
K(me2)VLRDDIQGITKPAIR 21–36 617.9 3+ 75/2.1e-05
463.8 4+ 81/4.3e-06
K(me2)VLRDNIQGITKPAIR 21–36 618.0 3+ 54/0.0028
DDIQGITKPAIR 25–36 664.2 2+ 30/0.26
443.1 3+ 64/8.6e-05
DNIQGITKPAIR 25–36 663.9 2+ 59/0.00017
443.0 3+ 68/5.3e-05
ISGLIYEETR 47–56 591.4 2+ 88/2.2e-07
GVLKVFLENVIR 57–68 694.4 2+ 57/0.00055
463.3 3+ 53/0.0014
VFLENVIR 61–68 495.5 2+ 53/0.0012
DAVTYTEHAK 69–78 567.8 2+ 49/0.21
KTVTAMDVVYALKR 80–93 532.8 3+ 80/2.6e-06
TVTAMDVVYALK 81–91 655.9 2+ 65/0.0052
AA - amino acids of the peptide numbered in the sequence of corresponding protein; M/Z - mass over charge ratio; Z – ion charge.
ac/me3 - acetylation/trimethylation, me1 - monomethylation, me2 - dimethylation,
ub – ubiquitination.
doi:10.1371/journal.pone.0015960.t006
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modifications of Lys-6 and Arg-18 by dimethylation, as well as
Lys-6 and Lys-17 ubiquitination (Table 6, Figure S4). Interesting-
ly, we sequenced two differentially modified N-terminal peptides
from the earlier uncharacterized variant of histone H4, encoded
by the HIST2H4B gene. These peptides were found in the protein
extracts from three of the participating persons. The HIST2H4B
variant differs from the canonical H4 only in its N-terminus where
VW residues are present instead of the SG pair (Table 6). The
variant specific peptide was sequenced in two differently modified
versions, one with Lys-8 and Lys-16 ubiquitination and the other
with Lys-8 monomethylation and Lys-16 dimethylation (Table 6,
Figure S4).
Discussion
Histone preparation from primary human adipocytes
Differential expression of histone variants as well as their PTMs
may serve as potential markers in the classification of diseases
affected by chromatin abnormalities. For example, a significant
decrease in the relative abundance of histone H2A variants
H2AFL and H2AFA/M was observed in primary chronic
lymphocytic leukemia cells as compared to normal B cells [61].
Mammalian histones show tissue-specific differences in their
expression and PTMs [62], as well as pronounced differences
between cell cultures and primary tissues [29]. Human subcuta-
neous fat tissue acquired from elective abdominal surgery could be
a readily obtainable source for the analysis of histone variants and
modifications related to obesity, type 2 diabetes and the metabolic
syndrome. In this work we performed a comparative analysis of
histone preparations from isolated nuclei and direct acid extracts
of human adipocytes obtained from such surgery. We developed a
straightforward and simple protocol for extraction of basic proteins
from the adipocytes, and using controlled proteolytic digestions of
these proteins and LC/MS/MS we revealed recovery of histone
variants from all subfamilies, namely H1, H2A, H2B, H3 and H4,
in amounts sufficient to make up to 100 nanoLC/MS/MS
analyses. Indeed, the direct acid extraction of adipocytes yielded
about 100 mg of protein with histone content of 60% –70% from
about 10 mL of fat cells. Direct homogenization of the cells in acid
also terminates enzymatic reactions which can change the pattern
of the histone code during the alternative cell fractionation. We
made six nanoLC/MS/MS analyses for each protein preparation
from six individuals, and produced a snapshot of the histone
variants in primary human adipocytes. This analysis uncovered
person-specific diversity in histone variants and in their PTMs,
and also demonstrated a requirement for additional histone
separation that should complement sequencing of peptide digests
to achieve comprehensive mapping of all histone isoforms. The
recently described liquid chromatography technique [26], capable
of identifying all of the major combinatorial histone codes present
in a sample, looks extremely promising for this purpose.
Chromatographic separation of individual modified histone
variants could also allow relative quantitation of modified isoforms
and their profiling in every individual acid extract from the fat
tissue, which in turn can be used to track variants and modified
isoforms related to diseases.
Histone variants of the primary adipocytes
The specific biology of the fat cell is determined during
adipogenesis via an intertwined network of transcription factors
and regulators with chromatin-modifying activities, which are
responsible for the establishment of the gene expression pattern of
the mature adipocyte [63]. Although the transcription factor
cascade controlling adipogenesis has been extensively studied, the
structure of chromatin and its histone composition in fat cells
remains to be determined [63]. We identified 5 variants of linker
and 14 variants of core histones in primary human adipocytes.
The core proteins encoded by the HIST1H2AC, HIST1H2BA,
HIST1H2BM, HIST1H2BN, HIST1H2BJ, HIST1H3I and
Figure 3. C-terminal peptide sequence of HIST1H2BN. ETD spectrum of the ion (M+6H)
6+ at m/z 547.4 corresponding to the peptide with
amino acids 101–128 in HIST1H2BN (GI: 119623520). The positions of z,y (C-terminal) and c (N-terminal) fragment ions are indicated in the spectrum
and in the corresponding peptide sequence, where the lower case (ph), (ac/me3), (ub) and (me2) designate modifications of the amino acids by
phosphorylation, acetylation/trimethylation, ubiquitination and dimethylation, respectively.
doi:10.1371/journal.pone.0015960.g003
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ably involved in bulk packaging of the nucleosome particles [58].
Among the other found isoforms H2AFX is an abundant histone
variant which upon phosphorylation participates in the repair of
double stranded DNA breaks [53] and in the associated chromatin
rearrangements [65]. The histone variants H2A.Z (H2AFZ) and
H3.3 (H3F3A/H3F3B) are implicated in specific transcription
regulation. Both H2A.Z and H3.3 affect nucleosome positioning
creating new positions and altering the relative occupancy of the
existing nucleosome position space [66]. H2A.Z variant associates
with gene promoters upon gene induction and helps in recruiting
the transcriptional machinery [67].
Notably, H2A.Z nucleosomes protect only approximately
120 bp of DNA and exhibit specific sequence preferences,
suggesting a novel mechanism of nucleosome organization for
the H2A.Z variant [68]. The histone fragment H2A (GI:2118981),
which we found for the first time at the protein level, lacks the
C-terminal part of a normal H2A and had earlier been annotated
Figure 4. Identification of alternative processing of histone variant H2AFX. ETD fragmentation spectra corresponding to four differentially
processed and modified N-termini of the isoform H2AFX (GI: 4504253). The positions of z,y (C-terminal) and c (N-terminal) fragment ions are indicated
in the spectra and in the presented peptide sequences with the lower case (ac), (ac/me3) (me1), (me2), (ph) and (ub) corresponding to modifications
of the amino acids by acetylation, acetylation/trimethylation, monomethylation, dimethylation, phosphorylation and ubiquitination, respectively.
(A) ETD spectrum of the ion (M+3H)
3+ at m/z 377.7 corresponding to the peptide with the amino acid positions 2–12 in H2AFX. The initial methionine
has been removed, the N-terminal serine acetylated and the arginine in the peptide was monomethylated. (B) ETD spectrum of the peptide
corresponding to the amino acid positions 5–18; the ion (M+3H)
3+ at m/z 570.2. The peptide is modified by acetylation/trimethylation,
phosphorylation, ubiquitination and two dimethylations. The mass difference of 181 between the fragment ions c3 and c4 corresponds to the
phosphorylated threonine. The mass difference of 242 between the fragment ions c5 and c6 corresponds to the ubiquitinated lysine. The mass
difference of 156 between the fragment ions c11 and c12 corresponds to the dimethylated lysine. The mass difference of 170 between the fragment
ions z12 and z13 corresponds to the acetylated/trimethylated lysine. (C) ETD spectrum of the peptide corresponding to the amino acid positions
5–18; the ion (M+3H)
3+ at m/z 567.4. The initial glycine has been acetylated after cleavage of the four N-terminal amino acids of the protein. The
peptide is also modified by a monomethylation and two ubiquitinations. The mass differences of 242 between the fragment ions z2 and z3, z12 and
z13 and c11 and c12, as well as the mass difference of 121 between the doubly charged fragment ions c11
2+ and c12
2+ correspond to the
ubiquitinated lysines. (D) ETD spectrum of the peptide corresponding to the amino acid positions 5–18; the ion (M+3H)
3+ at m/z 527.6. The N-
terminal glycine is acetylated. The peptide is also modified by monomethylation, phosphorylation and dimethylation. The mass difference of 156
between the fragment ions c9 and c10 corresponds to the dimethylated lysine. The mass difference of 167 between the fragment ions c12 and c13
corresponds to the phosphorylated serine.
doi:10.1371/journal.pone.0015960.g004
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H2A fragment could participate in the organization of specific
nucleosomes associated with transcriptionally active chromatin in
human adipocytes. It should be noted that we sequenced peptides
specific to H2A fragment and to each of the other three newly
identified variants (HIST1H2BN, the protein ‘‘similar to
H2AFY2’’ and HIST2H4B) from several subjects.
Only one H4 protein has been found in humans earlier as the
product of HIST1H4A-L/HIST2H4A-B/HIST4H4 genes [58,64].
We found the additional variant HIST2H4B, which in mature
form differs from the canonical H4 in the first two amino acid
residues. The function of this additional H4 variant in primary
human adipocytes remains to be established. The protein ‘‘similar
to H2AFY2’’ is analogous to macroH2A.2 variant histones, which
replace conventional H2A in a subset of nucleosomes where they
repress transcription. We also found H2AFY, which is a
macroH2A1 enriched on the inactive X chromosome in female
mammalian cells, where it functions to maintain gene silencing
[69]. This may reflect the fact that all preparations were made
from the fat tissue of female subjects. Accordingly, H2A.Z is
known to incorporate into the promoter regions of estrogen
receptor target genes upon gene induction [70] and to help in
recruiting the transcriptional machinery [67]. H2A.Z-containing
nucleosomes exhibit altered linker histone binding [66]. Two
identified linker histones are encoded by HIST1H1E and
HIST1H1T replication-dependent histone genes [64]. However,
the finding of HIST1H1T, H1FOO and H1FNT in the
adipocytes was surprising, because these variants are considered
to be oocyte or testis specific [48–50]. Additionally, we sequenced
specific peptides from the HIST1H2BA variant that also have
been described as a testis/sperm-specific replacement histone H2B
with unknown biological function [56]. Thus, a specific subset of
the H2A, H2B and linker histone variants identified in our study
may contribute to a distinct chromatin structure interacting with
transcription factors and chromatin-modifying regulators respon-
sible for the establishment of the gene expression pattern [63] that
drives the specialized biology of adipocyte cells.
Diversity of histone modifications in the adipocytes
Analyzing cell extracts from six subjects we identified 78 PTMs
in the histone proteins with 68 modifications being found for the
first time. The vast majority of the modified peptides were found
by sequencing of the multiply charged ions using ETD (Tables 2,
3, 4, 5, 6), while CID analyses revealed a limited number of PTMs.
We also identified alternative N-terminal processing of H2AFY, as
well as complex differential N-terminal processing of H2AFX.
Heterogeneity of N-terminal processing was detected in the
samples from different subjects, as well as in the acid extract from
adipocytes of the same person. It is well known that a majority of
the functionally important modifications of the core histones are
localized in their N-terminal tails [19]. We identified the N-
terminal regions of mature histones H1, H2A, H2B and H4, while
were not able to find the very N-terminal peptide corresponding to
histone H3. All the N-terminal peptides from both H3 variants
that we sequenced from six different subjects were starting from
the amino acid residue 19 of the corresponding initial translation
product. We suggest that despite the successful application of ETD
for sequencing of several peptides with multiple modifications, the
N-terminus of H3 in the primary human adipocytes is so heavily
and differentially modified that its heterogeneous products did not
pass the MS/MS quality criteria used for identification in this
study.
We found methylation of H3.3 at Lys-28, which was earlier
linked to gene repression and shown to be enriched in inactive X
chromosome chromatin [62]. Similarly, the H4 Lys-21 methyla-
tion, which we identified in several subjects, maintains silent
chromatin. Drosophila female X chromosome has significantly
increased levels of Lys-21 methylation in H4 compared to that of
males [71]. These modifications in H3.3 and H4 from the fat of
female subjects are in line with identification of H2AFY and the
protein ‘‘similar to H2AFY2’’, the variant histones that most
probably function to maintain gene silencing and inactive X
chromosome in female mammalian cells [69]. Additionally, the
methylation at Lys-28 in H3 is known to be involved in
establishment of the gene expression pattern of mature adipocytes
[63]. However, we did not find many identical histone
modifications in adipocytes from six different individuals. Only
23 out of 78 histone modifications were found in the samples from
two or more subjects. Moreover, the diversity of histone
modifications increased with the number of subjects analyzed.
For instance, Figure 2 demonstrates sequences of six differentially
modified peptides corresponding to the N-terminus of H2AFZ.
Only one of these peptides (Figure 2F) was found during the
systematic analyses of the cell extracts from six subjects, which
identified 78 PTMs. The other five peptides differentially
processed by removal of the N-terminal methionine, methylation,
acetylation/trimethylation, phosphorylation and ubiquitination
(Figure 2A–E) were found in the cell extracts from five other
subjects during the optimization stage of our proteomic study.
Thus, analyses of more subjects resulted in detection of eleven
additional modifications in the N-terminal tail of H2AFZ. These
findings demonstrate that histone modifications in primary human
adipocytes are extremely heterogeneous and person specific.
The adipose tissue and its major cell type the adipocyte is a
prime mover in the coordination of energy storage with energy
utilization and food intake. Metabolic diseases emanating from the
adipose tissue and the adipocytes include obesity, lipodystrophy,
type 2 diabetes, hypertension, cardiovascular disease and dyslipi-
demia. These are major diseases that are rapidly increasing in
incidence worldwide. We are still far from understanding the
molecular underpinnings, but this work makes it possible to study
epigenetic regulation of the histones in adipocytes in relation to
diseases. Subcutaneous adipose tissue is comparatively accessible
for biopsies. Correlation studies of histone variants and their
modifications in fat cells with disease characteristics could
therefore identify disease-specific histone marks. The direct acid
extraction protocol, which we have developed in this work, may,
moreover, allow the conduction of personal epigenetic analyses of
the adipose tissue for profiling of histone modifications related to
obesity, type 2 diabetes and the metabolic syndrome; as well as for
prescription of individual medical treatments.
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